Clicky

Puma Biotechnology Inc(PBYI) News

Date Title
Jul 23 Should Value Investors Buy Puma Biotechnology (PBYI) Stock?
May 28 Puma Biotechnology to Join Russell 3000 Index
May 26 With 49% ownership, Puma Biotechnology, Inc. (NASDAQ:PBYI) has piqued the interest of institutional investors
May 24 Puma Biotechnology (PBYI) Falls 38% in 3 Months: Here's Why
May 23 Puma Biotechnology Announces Publication of Alisertib Abstract Titles for the 2024 ASCO Annual Meeting
May 5 Analysts Have Lowered Expectations For Puma Biotechnology, Inc. (NASDAQ:PBYI) After Its Latest Results
May 4 Puma Biotechnology First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
May 3 Puma Biotechnology, Inc. (NASDAQ:PBYI) Q1 2024 Earnings Call Transcript
May 3 Puma Biotechnology's (PBYI) Q1 Earnings and Revenues Beat
May 3 Puma Biotechnology Inc (PBYI) Q1 2024 Earnings Call Transcript Highlights: A Detailed Review of ...
May 2 Puma Biotechnology Inc (PBYI) Reports Q1 Financial Results, Misses Analyst Revenue and EPS Forecasts
May 2 Puma Biotechnology Reports First Quarter Financial Results
Apr 29 Is Puma Biotechnology, Inc. (NASDAQ:PBYI) A High Quality Stock To Own?
Apr 26 What's in Store for Puma Biotechnology (PBYI) in Q1 Earnings?
Apr 18 Puma Biotechnology to Host Conference Call to Discuss First Quarter 2024 Financial Results
Apr 8 Puma Biotechnology (NASDAQ:PBYI) shareholders have earned a 93% return over the last year
Apr 3 Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Mar 22 Puma Biotechnology (PBYI) Soars 14.0%: Is Further Upside Left in the Stock?
Mar 22 Do Puma Biotechnology's (NASDAQ:PBYI) Earnings Warrant Your Attention?
Mar 20 Puma Biotechnology Announces FDA Allowance to Proceed Under IND for Alisertib in HER2-Negative, Hormone Receptor-Positive Metastatic Breast Cancer